Equities
  • Price (EUR)15.18
  • Today's Change0.088 / 0.58%
  • Shares traded5.00
  • 1 Year change-4.68%
  • Beta0.8538
Data delayed at least 15 minutes, as of Jul 11 2025 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sonic Healthcare Limited is a global provider of medical diagnostic services. The Company’s segments include Laboratory, Radiology, and Other. The Laboratory segment includes pathology/clinical laboratory services provided in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland and Belgium. The Radiology segment includes diagnostic imaging services provided in Australia. The Other segment includes corporate office functions, medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The Company’s Healthcare’s Australian Clinical Services division (Sonic Clinical Services) is a medical center operator (under the Independent Practitioner Network brand) and occupational health provider (under the Sonic HealthPlus brand). Sonic Clinical Services operates in partnership with approximately 2,000 general practitioners working in more than approximately 200 centers across Australia.

  • Revenue in AUD (TTM)9.33bn
  • Net income in AUD545.47m
  • Incorporated1934
  • Employees42.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SHL:ASX since
announced
Transaction
value
LADR Der Laborverbund Dr. Kramer & Kollegen GbRDeal completed09 Dec 202409 Dec 2024Deal completed-4.73%447.03m
Data delayed at least 20 minutes, as of Jul 11 2025 07:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.